RecruitingPhase 3NCT06937086Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b StudySponsor: Eli Lilly and CompanyAnaheim, CA · Beverly Hills, CA · Los Alamitos, CA · +34 more sites
RecruitingPhase 3NCT06937099Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or OverweightSponsor: Eli Lilly and CompanyAnaheim, CA · Beverly Hills, CA · Los Alamitos, CA · +32 more sites
RecruitingPhase 3NCT07564414A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose WeightSponsor: Novo Nordisk A/SEscondido, CA · La Mesa, CA · +96 more sites
Not yet recruitingPhase 3NCT07881458A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 DiabetesSponsor: Eli Lilly and CompanyLos Alamitos, CA · Los Angeles, CA · +23 more sites